2016 Research Fellow: Dr. Amanda Redig

Dr. Amanda Redig

Amanda J. Redig, MD, PhD Lowe Center for Thoracic Oncology Dana-Farber Cancer Institute

A Breath of Hope Lung Foundation is proud to announce the winner of the 2016 Women & Lung Cancer Fellowship: Amanda Redig, MD, PhD, Lowe Center for Thoracic Oncology at the Dana-Farber Cancer Institute.

Dr. Redig is pursuing a career as a translational investigator and thoracic oncologist. Her primary career goal is to help transform the way we treat lung cancer. While she notes the incredible privilege of seeing the advances in biotechnology, genetics and molecular biology during her medical education, she has also been witness to the sorrow, helplessness and senseless losses among her own patients with advanced lung cancer. This experience coupled with an inquisitive spirit motivate her to improve the survival rate of lung cancer.

The primary objective of Dr. Redig’s lung cancer research is to utilize primary tumor specimens and clinical outcomes from patients with a) EGFR TKI naive NSCLC and b) acquired resistance to erlotinib to quantify genomic complexity as a biomarker; develop predictive models to further characterize acquired resistance; and assess genomic complexity to identify clinically meaningful hallmarks of the disease in women.

Congratulations Dr. Redig and welcome to the A Breath of Hope family!


Progress Reports: Dr. Amanda Redig